Endocarditis Infective
10
4
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
20%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
Transthoracic Echocardiography in Assessing Patients With Suspected Endocarditis
San Matteo Endocarditis Registry STEADY
The Role of Polymerase Chain Reaction in the Management of Patients With Infective Endocarditis
Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.
Prognosis and Management of Infective Endocarditis Using the Clinical Data Warehouse From AP-HP
Antibiotics Vs Antibiotics and Surgical ThERapy for Infective Endocarditis
Study of the Prognosis of Infectious Endocarditis (EPEI)
ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis
Contemporary Transvenous Lead Extraction Outcomes